Doorgaan naar hoofdcontent

Human medicines European public assessment report (EPAR): Yervoy, ipilimumab, Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms, Date of authorisation: 13/07/2011, Revision: 50, Status: Authorised

Human medicines European public assessment report (EPAR): Yervoy, ipilimumab, Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms, Date of authorisation: 13/07/2011, Revision: 50, Status: Authorised